| Group 1 AR (N = 21) | Group 2 AR + LD (N = 49) | Group 3 AR + (H)MR (N = 55) | Group 4 M/BD (N = 24) | Group differences with Bonferroni correction (significant results, only)d | p-value | Group differences for planned contrasts representing increasing risk for BD (significant results, only)d | p-value | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | M | SD | M | SD | M | SD | M | SD |  |  |  |  |
Age | 23.7 | 4.8 | 24.5 | 5.1 | 23.4 | 4.0 | 25.6 | 4.5 | Â | Â | Â | Â |
 | N | % | N | % | N | % | N | % |  |  |  |  |
Sex | ||||||||||||
 Female | 12 | 57.1 | 33 | 67.3 | 32 | 58.2 | 8 | 33.3 | G2 vs G4: Chi2 = 7.570 | 0.036 | G1 + G2 + G3 vs G4: Chi2 = 6.565 | 0.039 |
Substance use | Â | Â | ||||||||||
 Nicotine usea | 9 | 42.9 | 21 | 44.7 | 22 | 41.5 | 12 | 60.0 |  |  |  |  |
 Alcohola | 4 | 19.0 | 16 | 34.0 | 21 | 39.6 | 8 | 40.0 |  |  |  |  |
 Cannabis usea | 11 | 52.4 | 22 | 46.8 | 30 | 56.6 | 15 | 75.0 |  |  | G1 + G2 + G3 vs G4: Chi2 = 3.652 | 0.056 |
 Amphetamine useb | 4 | 19.0 | 5 | 10.6 | 9 | 17.0 | 5 | 25.0 |  |  |  |  |
 Hallucinogen useb | 3 | 14.3 | 6 | 12.8 | 6 | 11.3 | 3 | 15.0 |  |  |  |  |
 Cocaine useb | 1 | 4.8 | 2 | 4.3 | 5 | 9.4 | 4 | 20.0 |  |  | G1 + G2 + G3 vs G4: Chi2 = 3.951 | 0.041 |
Diagnoses according to DSM-IV (current or lifetime)# | Â | Â | ||||||||||
 Mental/behavioral dis. due to psychoactive substance use (F1x.x) | 2 | 9.5 | 11 | 22.4 | 9 | 16.4 | 4 | 16.7 |  |  |  |  |
  Mental/behavioral dis. due to use of alcohol (F10.x) | 1 | 4.8 | 9 | 18.4 | 7 | 12.7 | 3 | 12.5 |  |  |  |  |
 Mental/behavioral dis. due to use of cannabis (F12.x) | 2 | 9.5 | 4 | 8.2 | 3 | 5.5 | 3 | 12.5 |  |  |  |  |
 Mood (Affective) Disorders (3x.x) | 0 | 0.0 | 49 | 100.0 | 35 | 63.6 | 24 | 100.0 | n.a |  | n.a |  |
  Manic episode/Bipolar affective disorder (wo Hypomania) (F30.x-F31.x) | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 24 | 100.0 | n.a |  | n.a |  |
  Depressive Episode (F32.x) | 0 | 0.0 | 20 | 40.8 | 7 | 12.7 | 0 | 0.0 | n.a |  | n.a |  |
  Recurrent depressive disorder (F33.x) | 0 | 0.0 | 24 | 49.0 | 27 | 49.1 | 0 | 0.0 | n.a |  | n.a |  |
  Persistent mood (affective) disorders (F34.x) | 0 | 0.0 | 5 | 10.2 | 1 | 1.8 | 0 | 0.0 | n.a |  | n.a |  |
 Neurotic, stress-related and somatoform disorders (F4x.x) | 7 | 33.3 | 10 | 20.4 | 17 | 30.9 | 8 | 33.3 |  |  |  |  |
  Phobic anxiety disorders and other anxiety disorders (F40.x-F41.x) | 4 | 19.0 | 6 | 12.2 | 15 | 27.3 | 6 | 25.0 |  |  | G1 + G2vsG3 + G4: Chi2 = 3.406 | 0.065 |
 Eating disorders (F50x) | 1 | 4.8 | 3 | 6.1 | 5 | 9.1 | 1 | 4.2 |  |  |  |  |
 Specific, mixed and other personality disorders (F60.x-F61.x) | 3 | 14.3 | 3 | 6.1 | 3 | 5.5 | 0 | 0.0 |  |  | G1vsG2 + G3 + G4: Chi2 = 2.928 | 0.087 |
 ADHD/ hyperkinetic disorder (F90.x)c | 1 | 4.8 | 4 | 8.2 | 7 | 12.7 | 3 | 12.5 |  |  |  |  |
 Comorbidity of above mentioned diagnoses 0 | 11 | 52.4 | 0 | 0.0 | 11 | 20.0 | 0 | 0.0 | G1 vs G2: Chi2 = 30.632 G1 vs G3: Chi2 = 8.655 G1 vs G4: Chi2 = 16.720 G2 vs G3: Chi2 = 11.913 | p < 0.001 p = 0.078 p < 0.001 p = 0.018 | G1vsG2 + G3 + G4: Chi2 = 27.810 G1 + G2 + G3vsG4: Chi2 = 5.340 | p < 0.001 p = 0.069 |
  1 | 6 | 28.6 | 25 | 51.0 | 18 | 32.7 | 13 | 54.2 | ||||
  2 +  | 4 | 19.0 | 24 | 49.0 | 26 | 47.3 | 11 | 45.8 |  |  |